This area has not received the attention it deserves, primarily because it has coincided with the pandemic, and federal and territorial resources have been focused on that. However, the Member may recall that, in October 2020, the federal Speech from the Throne invited provinces and territories to participate in federal, provincial, and territorial discussions on a national strategy for high-cost drugs for rare diseases, and in fact, the NWT has been participating in that dialogue. There is a public engagement going on now on high-cost drugs for rare diseases, and it continues until March 26th.
A second FPT forum that we've been involved with has to do with increasing our participation in the pan-Canadian Pharmaceutical Alliance. This is an alliance that negotiates with pharmaceutical companies on volume purchases of drugs in order to reduce the costs. Thank you.